The debate highlighted that G2019S shows elevated baseline RAB10 phosphorylation, but it's unclear whether this represents true signal amplification during lysosomal swelling or just a higher activity floor. This distinction is crucial for understanding disease mechanisms and therapeutic targeting.
Source: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352 (Analysis: SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867)
RAB29 functions as a gatekeeper—when lysosomes swell, RAB29-GTP increases, recruits LRRK2, and G2019S hyperphosphorylates RAB10 disproportionately. The amplification is RAB29-dependent. Strategic pivot: RAB29 serves as predictive biomarker rather than drug target. RAB29 knockout in G2019S patient-derived neurons would determine if amplification requires RAB29.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["RAB29 GTPase Activity"]
B["Recruitment to Stressed Lysosomes"]
C["Enhanced LRRK2-mediated Rab Phosphorylation"]
D["Lysosomal Dysfunction"]
E["Autophagy Impairment"]
F["Neuronal Death"]
G["Modifier of LRRK2 Pathogenesis"]
A --> B
B --> C
C --> D
D --> E
E --> F
A --> G
G --> C
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
5 citations5 with PMIDValidation: 0%3 supporting / 2 opposing
✓For(3)
No supporting evidence
No opposing evidence
(2)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-26 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Therapeutic/Mechanistic Hypotheses Addressing LRRK2 Signal Amplification vs. Baseline Elevation
Hypothesis 1: G2019S Acts as a Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependent Recruitment
Mechanism: G2019S specifically hyperactivates LRRK2 when recruited to swelling lysosomes via RAB29, creating a pathogenic positive feedback loop where membrane stress increases RAB10 phosphorylation more than wild-type.
Target Gene/Protein: LRRK2 (G2019S) + RAB29 axis
Supporting Evidence:
RAB29 pathogenic mutations (PARK23) cause early-onset Parkinsonism (PMID: 28165
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Critical Evaluation of LRRK2 Hypotheses
Overview
The core question—whether G2019S increases signal amplification during lysosomal swelling versus merely elevating the baseline activity floor—requires distinguishing between these mechanistically distinct possibilities. Most hypotheses conflate these, and none provide decisive evidence for either model.
Hypothesis 1: Lysosomal Volume-Sensing Amplifier via RAB29
Weak Links
Recruitment enhancement not demonstrated: The cited PMIDs establish that RAB29 recruits LRRK2 to stressed lysosomes, but do not show G2019S specifica
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Feasibility Assessment: LRRK2 G2019S Signal Amplification vs. Baseline Elevation Hypotheses
Executive Summary
The core mechanistic question—whether LRRK2 G2019S drives pathology through amplified signaling during lysosomal stress versus simply elevating the basal activity floor—carries significant therapeutic implications. If amplification is pathogenic, partial kinase inhibition strategies become rational; if elevated baseline alone drives neurodegeneration, complete inhibition may be required. This distinction will shape trial design, dose selection, and acceptable safety profiles.
B
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
IF CRISPR-Cas9-mediated RAB29 knockout is performed in G2019S patient-derived iPSC neurons, THEN RAB10 phosphorylation at Thr73 will be reduced by at least 50% compared to isogenic G2019S control neurons within 6 weeks of neuronal differentiation.
pendingconf: 0.72
Expected outcome: At least 50% reduction in phospho-RAB10 (Thr73) levels in RAB29 knockout G2019S neurons relative to G2019S parental neurons, as measured by multiplex immunoassay
Falsified by: No significant change (<20%) in phospho-RAB10 (Thr73) levels between RAB29 knockout and parental G2019S neurons, indicating LRRK2 G2019S can hyperphosphorylate RAB10 independently of RAB29
Method: G2019S patient-derived iPSC lines (n≥3 per genotype) subjected to CRISPR-Cas9 RAB29 knockout, differentiated to forebrain excitatory neurons for 5-6 weeks, with phospho-RAB10 quantified by electrochemical luminescence assay (Meso Scale Discovery) and total RAB10 as loading control
IF RAB29 is overexpressed via AAV-mediated transduction in non-swollen lysosomes of G2019S patient-derived neurons, THEN LRRK2-mediated RAB10 phosphorylation will not increase above baseline, whereas osmotic lysosome swelling will rescue hyperphosphorylation in a RAB29-dependent manner within 3 weeks post-infection.
pendingconf: 0.68
Expected outcome: AAV-RAB29 overexpression alone will not elevate phospho-RAB10; however, pretreatment with hypotonic medium (5-10 min) to induce lysosome swelling will produce significantly higher phospho-RAB10 in RAB29-overexpressing cells versus RAB29 knockout cells, as quantified 72 hours post-treatment
Falsified by: RAB29 overexpression alone significantly increases (>30%) phospho-RAB10 levels without lysosome swelling, contradicting the gatekeeper model, OR RAB29 knockout neurons retain normal RAB10 hyperphosphorylation after lysosome swelling
Method: G2019S patient-derived iPSC neurons (n≥3 lines) transduced with AAV9-RAB29 or AAV9-GFP control, followed by vehicle or hypotonic stress (90% osmolarity reduced for 5 min), with phospho-RAB10 measured via MSD assay and subcellular fractionation confirming lysosomal localization by Western blot for LAMP2
Knowledge Subgraph (0 edges)
No knowledge graph edges recorded
3D Protein Structure
🧬
RAB29 — Search for structure
Click to search RCSB PDB